Yunlong Shan

705 total citations
28 papers, 522 citations indexed

About

Yunlong Shan is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yunlong Shan has authored 28 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Immunology. Recurrent topics in Yunlong Shan's work include Garlic and Onion Studies (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Mesenchymal stem cell research (3 papers). Yunlong Shan is often cited by papers focused on Garlic and Onion Studies (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Mesenchymal stem cell research (3 papers). Yunlong Shan collaborates with scholars based in China. Yunlong Shan's co-authors include Aiyun Wang, Zhonghong Wei, Yin Lu, Zhaoguo Liu, Wenxing Chen, Tao Li, Siliang Wang, Yuping Liu, Zhijie Zhu and Pingting Zhu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Yunlong Shan

25 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunlong Shan China 11 276 121 91 80 65 28 522
Shan Kuang China 15 318 1.2× 79 0.7× 64 0.7× 100 1.3× 50 0.8× 21 667
A.M. Joubert South Africa 16 341 1.2× 90 0.7× 78 0.9× 78 1.0× 42 0.6× 47 651
Parul Gupta India 13 563 2.0× 85 0.7× 106 1.2× 115 1.4× 63 1.0× 26 846
Yeong‐In Yang South Korea 13 247 0.9× 84 0.7× 61 0.7× 82 1.0× 98 1.5× 18 615
Ekambaranellore Prakash Taiwan 14 521 1.9× 151 1.2× 106 1.2× 62 0.8× 87 1.3× 23 770
Sun‐Nyoung Yu South Korea 14 380 1.4× 50 0.4× 110 1.2× 109 1.4× 51 0.8× 27 654
Xihan Guo China 15 329 1.2× 108 0.9× 54 0.6× 107 1.3× 48 0.7× 36 568
Haiming Ding United States 15 514 1.9× 95 0.8× 162 1.8× 79 1.0× 45 0.7× 30 898
Meng‐Liang Lin Taiwan 13 319 1.2× 106 0.9× 83 0.9× 98 1.2× 76 1.2× 27 619
Changbao Chen China 16 349 1.3× 157 1.3× 70 0.8× 131 1.6× 59 0.9× 57 729

Countries citing papers authored by Yunlong Shan

Since Specialization
Citations

This map shows the geographic impact of Yunlong Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunlong Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunlong Shan more than expected).

Fields of papers citing papers by Yunlong Shan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunlong Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunlong Shan. The network helps show where Yunlong Shan may publish in the future.

Co-authorship network of co-authors of Yunlong Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Yunlong Shan. A scholar is included among the top collaborators of Yunlong Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunlong Shan. Yunlong Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Xin, Peng Cheng, Yuan Fang, et al.. (2025). Yinzhihuang formula modulates the microbe‒gut‒liver axis and bile acid excretion to attenuate cholestatic liver injury. Phytomedicine. 139. 156495–156495. 3 indexed citations
2.
Zhang, Mengying, Zhonghong Wei, Bin Wei, et al.. (2025). Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy. Cell Host & Microbe. 33(6). 915–931.e9. 4 indexed citations
3.
Wu, Yunhao, Li Zhang, Shengda Cao, et al.. (2025). Lycium barbarum Glycopeptide Alleviates Neomycin‐Induced Ototoxicity by Inhibiting Tryptophan Hydroxylase‐Mediated Serotonin Biosynthesis. Advanced Science. 12(29). e2405850–e2405850. 1 indexed citations
4.
Shan, Yunlong, et al.. (2025). Study on the cavitation erosion of a single bubble collapse near a rigid wall based on chronoamperometry. International Journal of Multiphase Flow. 193. 105394–105394.
5.
Deng, Rui, Mingyuan Liu, Hong Zhu, et al.. (2025). Ginseng polysaccharides ameliorate colorectal tumorigenesis through Lachnospiraceae-mediated immune modulation. International Journal of Biological Macromolecules. 307(Pt 2). 142015–142015. 8 indexed citations
6.
Luo, Xin, Ting Mao, Xilin Wang, et al.. (2025). Synergistic effects of ferulic acid and wogonin on cholestatic liver injury via gut microbiota modulation. npj Biofilms and Microbiomes. 11(1). 231–231.
7.
Li, Xiaoman, et al.. (2024). Study on Non-Spherical Deformation Velocity of a Single Cavitation Bubble. Processes. 12(3). 553–553. 2 indexed citations
8.
Shan, Yunlong, Mengying Zhang, Jing Wang, et al.. (2024). Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges. Signal Transduction and Targeted Therapy. 9(1). 242–242. 30 indexed citations
9.
Zhang, Qixiang, Yunlong Shan, Luping Shen, et al.. (2024). Renal remodeling by CXCL10-CXCR3 axis-recruited mesenchymal stem cells and subsequent IL4I1 secretion in lupus nephritis. Signal Transduction and Targeted Therapy. 9(1). 325–325. 3 indexed citations
10.
Ni, Qi, Le Zhen, Zhu Zeng, et al.. (2024). Mesenchymal stromal cells restrain the Th17 cell response via L-amino-acid oxidase within lymph nodes. Cell Death and Disease. 15(9). 640–640. 2 indexed citations
12.
Cheng, Peng, Jiawei Wu, Rui Deng, et al.. (2023). Capsaicin shapes gut microbiota and pre-metastatic niche to facilitate cancer metastasis to liver. Pharmacological Research. 188. 106643–106643. 45 indexed citations
13.
Ao, Luyao, Shencun Fang, Kexin Zhang, et al.. (2022). Sequence-dependent synergistic effect of aumolertinib-pemetrexed combined therapy on EGFR-mutant non-small-cell lung carcinoma with pre-clinical and clinical evidence. Journal of Experimental & Clinical Cancer Research. 41(1). 163–163. 6 indexed citations
14.
Shan, Yunlong, Fang Wang, Zhonghong Wei, & Yin Lu. (2021). Synthetic lethality theory approaches to effective substance discovery and functional mechanisms elucidation of anti-cancer phytomedicine. Phytomedicine. 91. 153718–153718. 7 indexed citations
15.
Peng, Cheng, Peiliang Shen, Yunlong Shan, et al.. (2021). Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy. Frontiers in Cell and Developmental Biology. 9. 626045–626045. 11 indexed citations
16.
Shan, Yunlong, Yuan Gao, Wei Jin, et al.. (2019). Targeting HIBCH to reprogram valine metabolism for the treatment of colorectal cancer. Cell Death and Disease. 10(8). 618–618. 33 indexed citations
17.
Shan, Yunlong, Ke Shi, Yuan Gao, et al.. (2019). Preclinical development of GR1501, a human monoclonal antibody that neutralizes interleukin-17A. Biochemical and Biophysical Research Communications. 517(2). 303–309. 3 indexed citations
18.
Shan, Yunlong, Zhonghong Wei, Tao Li, et al.. (2015). Tetramethylpyrazine inhibits hypoxia-induced migration and invasion of breast cancer cell line MDA-MB-435S in vitro. Tumori. 35(6). 621–629. 1 indexed citations
19.
20.
Shen, Cunsi, Siliang Wang, Yunlong Shan, et al.. (2014). Chemomodulatory efficacy of lycopene on antioxidant enzymes and carcinogen-induced cutaneum carcinoma in mice. Food & Function. 5(7). 1422–1431. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026